Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

46 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Umbilical cord-derived mesenchymal stromal cells: predictive obstetric factors for cell proliferation and chondrogenic differentiation.
Avercenc-Léger L, Guerci P, Virion JM, Cauchois G, Hupont S, Rahouadj R, Magdalou J, Stoltz JF, Bensoussan D, Huselstein C, Reppel L. Avercenc-Léger L, et al. Among authors: virion jm. Stem Cell Res Ther. 2017 Jul 5;8(1):161. doi: 10.1186/s13287-017-0609-z. Stem Cell Res Ther. 2017. PMID: 28676126 Free PMC article. Clinical Trial.
The clinical value of concomitant Epstein Barr virus (EBV)-DNA load and specific immune reconstitution monitoring after allogeneic hematopoietic stem cell transplantation.
D'Aveni M, Aïssi-Rothé L, Venard V, Salmon A, Falenga A, Decot V, Virion JM, Wang Y, Clement L, Latger-Cannard V, Tomowiak C, Stoltz JF, Bordigoni P, Bensoussan D. D'Aveni M, et al. Among authors: virion jm. Transpl Immunol. 2011 May;24(4):224-32. doi: 10.1016/j.trim.2011.03.002. Epub 2011 Apr 2. Transpl Immunol. 2011. PMID: 21440066
Combination of Epstein-Barr virus nuclear antigen 1, 3 and lytic antigen BZLF1 peptide pools allows fast and efficient stimulation of Epstein-Barr virus-specific T cells for adoptive immunotherapy.
Wang Y, Aïssi-Rothe L, Virion JM, De Carvalho Bittencourt M, Ulas N, Audonnet S, Salmon A, Clement L, Venard V, Jeulin H, Stoltz JF, Decot V, Bensoussan D. Wang Y, et al. Among authors: virion jm. Cytotherapy. 2014 Jan;16(1):122-34. doi: 10.1016/j.jcyt.2013.07.008. Epub 2013 Oct 1. Cytotherapy. 2014. PMID: 24094498
Prevention of EBV-induced B-lymphoproliferative disorder by ex vivo marrow B-cell depletion in HLA-phenoidentical or non-identical T-depleted bone marrow transplantation.
Cavazzana-Calvo M, Bensoussan D, Jabado N, Haddad E, Yvon E, Moskwa M, Tachet des Combes A, Buisson M, Morand P, Virion JM, Le Deist F, Fischer A. Cavazzana-Calvo M, et al. Among authors: virion jm. Br J Haematol. 1998 Nov;103(2):543-51. doi: 10.1046/j.1365-2141.1998.00972.x. Br J Haematol. 1998. PMID: 9827933 Free article.
Effects of medical therapy on outcome assessment using exercise thallium-201 single photon emission computed tomography imaging: evidence of a protective effect of beta-blocking antianginal medications.
Marie PY, Danchin N, Branly F, Angioï M, Grentzinger A, Virion JM, Brouant B, Olivier P, Karcher G, Juillière Y, Zannad F, Bertrand A. Marie PY, et al. Among authors: virion jm. J Am Coll Cardiol. 1999 Jul;34(1):113-21. doi: 10.1016/s0735-1097(99)00156-4. J Am Coll Cardiol. 1999. PMID: 10399999 Free article.
Antithrombotic therapy is associated with better survival in patients with severe heart failure and left ventricular systolic dysfunction (EPICAL study).
Echemann M, Alla F, Briançon S, Juillière Y, Virion JM, Mertès PM, Villemot JP, Zannad F, Aliot E, Breton Ch, KhalifE K, Neimann JL, Allam S, Admant P, Baille N, Bellanger P, D'Hôtel R, Dambrine P, Dodet JF, Graille M, Kessler M, Rebeix G, Royer, Saulnier JP, Thisse JY, Trutt B, Vidal P, Vuillemin MCh, Delahaye, Ducimetière P, Fagnani F, Guize L; EPICAL Investigators. Epidémiologie de l'Insuffisance Cardiaque Avancée en Lorraine. Echemann M, et al. Among authors: virion jm. Eur J Heart Fail. 2002 Oct;4(5):647-54. doi: 10.1016/s1388-9842(02)00028-4. Eur J Heart Fail. 2002. PMID: 12413509 Free article.
46 results